Carolyn R. Sikes
Profile
Carolyn R.
Sikes is currently working as a Principal at Neos Therapeutics, Inc. She previously worked as a Principal at Pfizer Pharmaceuticals, Inc. She holds a doctorate degree from Duke University.
Former positions of Carolyn R. Sikes
| Companies | Position | End |
|---|---|---|
Pfizer Pharmaceuticals, Inc.
 Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products. | Corporate Officer/Principal | - |
| NEOS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Carolyn R. Sikes
| Duke University | Doctorate Degree |
Experiences
Positions held
Linked companies
| Private companies | 2 |
|---|---|
Neos Therapeutics, Inc.
 Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX. | Health Technology |
Pfizer Pharmaceuticals, Inc.
Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products. | Health Technology |
- Stock Market
- Insiders
- Carolyn R. Sikes
